Delirium and Delirium Severity Predict the Trajectory of the Hierarchical Assessment of Balance and Mobility in Hospitalized Older People: Findings From the DECIDE Study by Richardson, Sarah et al.
1
Journals of Gerontology: Medical Sciences
cite as: J Gerontol A Biol Sci Med Sci, 2021, Vol. XX, No. XX, 1–5
doi:10.1093/gerona/glab081
Advance Access publication March 16, 2021
© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits 
unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Research Report
Delirium and Delirium Severity Predict the Trajectory of 
the Hierarchical Assessment of Balance and Mobility in 
Hospitalized Older People: Findings From the DECIDE 
Study
Sarah  Richardson, MBBS,1,2,  James  Murray, MSc,1,2 Daniel  Davis, PhD,3,  
Blossom  C.  M.  Stephan, PhD,4,  Louise  Robinson, PhD,5 Carol  Brayne, MD,6,  
Linda Barnes,6 Stuart Parker, MD,5 Avan A. Sayer, PhD,1,2 Richard M. Dodds, PhD,1,2,*,†,  
and Louise Allan, PhD7,†,  
1AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon 
Tyne, UK. 2NIHR Newcastle Biomedical Research Centre, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation 
Trust, UK. 3MRC Unit for Lifelong Health and Ageing at UCL, London, UK. 4Institute of Mental Health, Division of Psychiatry and Applied 
Psychology, School of Medicine, Nottingham University, UK. 5Population Health Sciences Institute, Faculty of Medical Sciences, 
Newcastle University, Newcastle upon Tyne, UK. 6Cambridge Public Health, University of Cambridge, UK. 7Centre for Research in Ageing 
and Cognitive Health, University of Exeter, UK.
*Address correspondence to: Richard Dodds, PhD, AGE Research Group, Translational and Clinical Research Institute, Faculty of Medical Sci-
ences. Biomedical Research Building, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, NE4 5PL UK. E-mail: richard.
dodds@newcastle.ac.uk 
†Joint senior authors.
Received: November 23, 2020; Editorial Decision Date: March 9, 2021
Decision Editor: Anne B. Newman, MD, MPH, FGSA
Abstract
Background: Delirium is common, distressing, and associated with poor outcomes. Despite this, delirium remains poorly recognized, resulting 
in worse outcomes. There is an urgent need for methods to objectively assess for delirium. Physical function has been proposed as a potential 
surrogate marker, but few studies have monitored physical function in the context of delirium. We examined if trajectories of physical function 
are affected by the presence and severity of delirium in a representative sample of hospitalized participants older than 65 years.
Method: During hospital admissions in 2016, we assessed participants from the Delirium and Cognitive Impact in Dementia study daily for 
delirium and physical function, using the Hierarchical Assessment of Balance and Mobility (HABAM). We used linear mixed models to assess 
the effect of delirium and delirium severity during admission on HABAM trajectory.
Results: Of 178 participants, 58 experienced delirium during admission. Median HABAM scores in those with delirium were significantly 
higher (indicating worse mobility) than those without delirium. Modeling HABAM trajectories, HABAM scores at first assessment were worse 
in those with delirium than those without, by 0.76 (95% CI: 0.49–1.04) points. Participants with severe delirium experienced a much greater 
perturbance in their physical function, with an even lower value at first assessment and slower subsequent improvement.
Conclusions: Physical function was worse in those with delirium compared to without. This supports the assertion that motor disturbances are 
a core feature of delirium and monitoring physical function, using a tool such as the HABAM, may have clinical utility as a surrogate marker 
for delirium and its resolution.
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Delirium is an acute and fluctuating neurocognitive disorder, 
specifically affecting attention and level of arousal. Delirium 
is common and distressing, affecting 15% of older hospital in-
patients (1), and is associated with poor outcomes, including mor-
tality, institutionalization, and cognitive decline (2,3). Delirium 
remains poorly recognized and documented, resulting in worse 
outcomes, and there remains a lack of evidence regarding how 
best to monitor delirium longitudinally, including recognizing de-
lirium resolution (1). Many of the cognitive tests currently used 
are not validated for repeated use, are burdensome, and rely 
heavily on testing cognition, which may be abnormal in people 
with dementia, with or without delirium (4). Therefore, there is an 
urgent need for reliable and reproducible methods of rapidly and 
objectively assessing for delirium.
Although delirium is primarily regarded as a cognitive dis-
order, motor disturbances have been proposed as a core feature of 
delirium and monitoring physical function has been suggested as 
a possible surrogate marker for delirium (5). However, previous 
work is limited by the use of measures of physical function which 
have significant floor effects in those with very limited or no mo-
bility (6). The Hierarchical Assessment of Balance and Mobility 
(HABAM) consists of 3 domains: balance, transfers, and mobility, 
which are scored based on observation of the patient (7,8). The 
HABAM assesses across the spectrum of function, from fully de-
pendent for pressure care to independent in transfers and mo-
bility, and has been shown to be valid and reliable (9). Despite 
being shown to predict prevalent delirium when measured on ad-
mission, the HABAM has not previously been examined longitu-
dinally in relation to delirium (10).
We aimed to describe the trajectories of HABAM over time in 
older, hospitalized patients and explore whether these trajectories 
varied by overall delirium status and delirium severity, along with 
exploring the effect of delirium on daily HABAM scores.
Method
Participants
This analysis uses data collected for the Delirium and Cognitive 
Impact in Dementia (DECIDE) study, which aimed to explore the 
association between delirium and cognitive function (3,11). The 
DECIDE study was nested within the Cognitive Function and Ageing 
Study II—Newcastle cohort (CFAS II-Newcastle), which provided a 
representative, population-based sample older than 65 years living 
within the catchment area of Newcastle upon Tyne Hospitals NHS 
Foundation Trust (12).
Recruitment
From 5th January 2016 to 5th January 2017, we invited participants 
from the CFAS II-Newcastle to participate in DECIDE on admission 
to hospital. We were alerted to admissions by a Recurring Admission 
Patient Alert attached to the participants’ electronic records. For par-
ticipants lacking capacity to consent, an appropriate personal con-
sultee was requested to provide written confirmation of willingness 
to participate. Participants were excluded if they lacked capacity to 
consent and it was not possible to identify or contact an appropriate 
personal consultee, they were receiving end-of-life care, they were 
being isolated for infection control reasons, or they were expected 
to be in hospital for less than 24 hours. Once recruited, we recorded 
baseline data including age, sex, frailty using the Clinical Frailty 
Scale (13), comorbidity using the Cumulative Illness Rating Scale 
(14), and place of residence. Admissions were classified as the care of 
a medical or surgical team, with the latter divided into elective and 
emergency admissions. Early mobilization was routine on all wards 
in the study, including physiotherapy assessment when needed.
Delirium and HABAM Assessments
Participants were seen daily for the DECIDE study, as far as possible, 
during their hospital admissions. Two research staff (S.R. and a spe-
cially trained research nurse) completed all of the assessments for the 
study. We ascertained delirium using a standardized approach based 
on the Diagnostic and Statistical Manual of Mental Disorders, fifth 
edition (DSM-5) criteria, described fully in the study protocol (11). 
In summary, the assessment combined objective testing of the par-
ticipant, and information gained from informants (usually nurses, 
next of kin or clinical records), with structured observations made 
by the assessor. Disturbance in attention was evaluated using months 
of the year backwards and digit span, and arousal was recorded 
using the Observational Scale of Level of Arousal and the modified 
Richmond Agitation and Sedation Scale (15). Disturbance in cog-
nition was evaluated using 3-item recall, 10 orientation questions, 
3 stage commands, and any evidence of perceptual disturbances 
along with observations by the examiner during the interview. Acute 
onset and fluctuating course, change from baseline, and evidence of 
underlying medical condition were obtained from informant his-
tory from nursing staff, next of kin, and clinical records. Delirium 
presence or absence, along with delirium severity according to the 
Memorial Delirium Assessment Scale (MDAS) (16), was determined 
on each assessment.
We also recorded HABAM score on each assessment based 
upon observation by the assessor along with collateral history 
from nursing and physiotherapy staff. Participants were not specif-
ically maneuvered for the purpose of the study but were observed 
throughout the interaction. Bedside clues such as the presence of 
zimmer frames and also signs at the patient bedside regarding levels 
of mobility (eg, WZF+1 = wheeled zimmer frame with assistance 
of one) were also noted. The medical notes were then reviewed for 
details regarding mobility during the preceding 24 hours, including 
any documentation by physiotherapists. If available, staff on the 
ward were asked how patients were mobilizing and transferring 
and whether any aids or assistance were required. Based on all 
of this information, we recorded scores for balance (out of 21), 
transfers (out of 18), and mobility (out of 26), with higher scores 
indicating better function (8).
Statistical Analysis
In line with previous work, each HABAM component was trans-
formed to lie in the range 0–1 by dividing the score obtained by the 
total score for each component (17). Also aligned to previous work, 
total HABAM score used in all analyses was calculated by summing 
the 3 individual items, giving a total score in the range 0–3, and then 
rescaled such that lower HABAM corresponded to better function. 
We used the previously developed cut points for the rescaled score: 
mild (≤1.25), moderate (1.26–1.74), and severe (≥1.75) functional 
impairment (17).
In instances where all 3 components were missing (n = 14 ob-
servations), no HABAM score was calculated. Where at least one 
other component was available (n  =  4 observations), the missing 
component was imputed based upon the mean of available compo-
nents, justified by the strong correlation seen previously between the 
3 components (8).
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We limited analysis to the first admission for participants during 
the study period with at least 2 documented HABAM scores. We 
also included only the first 14 days of admission due to the scar-
city of data beyond this, as the majority of patients were discharged 
by this point. Characteristics of interest were first assessed for nor-
mality through use of the Shapiro–Wilks test. We assessed differ-
ences in HABAM scores, and other baseline variables, between those 
with and without delirium using student t test (parametric) and the 
Wilcoxon rank-sum test (nonparametric). The chi-squared test was 
used for assessing categorical variables.
We examined HABAM trajectories by fitting linear mixed-
effects models, taking into account clustering at the level of indi-
vidual patients. We tested for differences in the intercept and slope 
of HABAM trajectories between patients with and without delirium 
during their admission. We additionally divided those with delirium 
into thirds based on their maximum recorded MDAS score: categor-
ized as mild, moderate, and severe. We then carried out a further 
linear mixed-effects model, with delirium subdivided into nonsevere 
(mild or moderate) and severe groups. Finally, in a separate model 
restricted to those with delirium during admission, we incorporated 
delirium diagnosis as a time-varying, binary predictor. This allowed 
for appraisal of the effect of delirium on daily HABAM score.
Patients who died during their selected admission were excluded 
in a sensitivity analysis. All statistical analyses were performed using 
R version 3.6.0 (www.r-project.org).
Results
Characteristics of Participants With and Without 
Delirium
The DECIDE study recruited 205 participants. Of these, 178 partici-
pants (53.9% female) had an admission with at least 2 valid HABAM 
scores and form the sample for the present analyses. The majority 
of participants (69.1%) were admitted under the care of a medical 
team. We found no differences in the age, sex, or frailty status of the 
27 participants who did not have at least 2 valid HABAM scores.
Fifty-eight participants (32.6%) experienced delirium during 
the selected admission. Of those with delirium, 42 (72.4%) were 
diagnosed as such at first assessment and 47 (81.7%) had first diag-
nosis of delirium within 48 hours of their first assessment. No par-
ticipants had delirium diagnosed beyond assessment Day 8 (please 
see Supplementary Figure 1). The characteristics of the sample are 
shown in Table 1. Those with delirium tended to have higher median 
HABAM scores (ie, worse performance) compared to those without 
and were frailer, older, and spent longer in hospital.
HABAM Trajectory in Those With and Without 
Delirium
Figure 1 illustrates the difference in baseline HABAM scores in 
those with and without delirium along with projections of im-
provement over the length of hospital stay, up to 14 days. The pres-
ence of delirium was associated with a higher HABAM score on 
first assessment, by an average of 0.76 points (95% CI: 0.49–1.04). 
HABAM scores improved on average over time. The mean daily 
improvement in those without delirium was 0.03 points (95% CI: 
0.01–0.06). Delirium was associated with a nonsignificant add-
itional daily improvement of 0.04 points (95% CI: −0.001, 0.074). 
Removing those who died during admission (n = 3) did not alter 
the findings.
HABAM Trajectories Stratified by Delirium Severity
Those with severe delirium (n = 16, 9.0%) experienced more severe 
impairment in their physical function than those without delirium, 
with HABAM scores just over 1 point higher at first assessment (co-
efficient [95% CI]: 1.13 [0.72, 1.54]). This contrasted with those 
with nonsevere delirium, where the HABAM score was only slightly 
higher compared to those without delirium (coefficient [95% CI]: 
0.62 [0.34, 0.90]). The improvement in HABAM score was more 
marked in the nonsevere delirium group, who showed an average 
daily improvement of 0.04 (95% CI: 0.02, 0.07) points greater than 
those without delirium, such that they had similar mean HABAM 
Table 1. Characteristics of Sample by Delirium Status
Variable Total (n = 178) Delirium (n = 58) No Delirium (n = 120) p Valuea
Age, mean (SD) 82.3 (6.42) 84.8 (6.31) 81.1 (6.13) .004
Sex: women, n (%) 96 (53.9) 32 (55.2) 64 (53.3) .944
Living in 24-h care, n (%) 11 (6.2) 6 (10.3) 5 (4.2) .109
Comorbidity score, mean (SD) 8.6 (4.4) 10.5 (4.2) 7.7 (4.2) <.001
Clinical frailty score, median [IQR] 4 [3, 5] 5 [5, 6] 4 [3, 5] <.001
Diagnosis of dementia, n (%) 19 (10.7) 16 (27.6) 3 (2.5) <.001
Admission type, n (%):    .218
 Medical 123 (69.1) 44 (75.9) 79 (65.8)  
 Surgical (elective) 31 (17.4) 6 (10.3) 25 (20.8)  
 Surgical (emergency) 24 (13.5) 8 (13.8) 16 (13.3)  
Length of admission, median [IQR] 7 [4, 14] 13 [9, 29] 5 [3, 8] <.001
Number of assessments, median [IQR] 5 [3, 7] 7 [6, 11] 4 [2, 5] <.001
Day of admission when HABAM first assessed, median [IQR] 1 [1, 2] 1 [1, 2] 2 [1, 2] .131
HABAM total scoreb, median [IQR] and components: 0.99 [0.31, 1.93] 1.4 [0.76, 2.01] 0.76 [0.04, 1.69] <.001
 Balance component 0.33 [0.0, 0.67] 0.52 [0.33, 0.67] 0.33 [0.0, 0.52] <.001
 Mobility component 0.54 [0.04, 0.65] 0.54 [0.42, 0.65] 0.42 [0.04, 0.65] <.001
 Transfers component 0.0 [0.0, 0.61] 0.33 [0.0, 0.83] 0.0 [0.0, 0.61] <.001
Notes: HABAM = Hierarchical Assessment of Balance and Mobility; IQR= interquartile range.
ap Value from appropriate test for difference between delirium status. Where characteristic of interest reported as median [IQR], Wilcoxon rank-sum test was 
used; where mean (SD), student t test was used; and where categorical, chi-squared test was used. bWith higher values indicating worse function (see Method 
section).
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scores to the nondelirium group by day 14. These findings are also 
shown in Supplementary Figure 2.
Change in HABAM Scores on Days With Delirium
When examining delirium status as a time-varying predictor, having 
delirium on a particular day was associated with a higher HABAM 
score (coefficient [95% CI]: 0.28 [0.15, 0.41]), indicating worse phys-
ical function, compared with days when delirium was not detected. 
To demonstrate this, Figure 2 shows HABAM profiles for 4 partici-
pants with fitted values from the longitudinal model. Improvement in 
HABAM score is seen as a participant moves from meeting criteria for 
delirium diagnosis to no delirium across assessments.
Discussion
Our study shows that trajectories of physical function in older, hospi-
talized people, measured using the HABAM, differ in those with and 
without delirium. Those with delirium, and especially those with se-
vere delirium, had worse physical function on admission. We also saw 
evidence of an improvement over time among those with delirium, 
although this appeared less marked in those with severe delirium.
A major strength of this work was that it was nested within 
CFAS II-Newcastle, a representative sample, including those with and 
without dementia. A further strength was the prospective delirium as-
certainment using a standardized approach based on DSM-5 criteria, 
which has subsequently been replicated in other studies (18). Despite 
very low rates of missing data, a limitation of our study was that not 
all participants were seen every day due to participant refusal, illness, 
or study capacity, with only 2 researchers collecting data. However, 
a median number of assessments of 5 and a median length of stay 
of 7  days demonstrate that the majority of participants were seen 
near daily during admission. A further potential limitation was that 
assessors were not blinded to delirium status when evaluating phys-
ical function, as both were recorded at the same time. However, the 
HABAM is designed as a primarily objective measure and previous 
work has demonstrated high interrater and test–retest reliability (9). 
Finally, we did not have information on patients’ HABAM score prior 
to admission which would have allowed us to place any improvement 
in the context of a patient’s baseline mobility.
In line with previous work, we have shown that people with de-
lirium have significantly worse physical function, measured using the 
HABAM, on first assessment (10). We have additionally shown that 
those with severe delirium have even greater derangement of their 
physical function. These findings suggest that measuring physical 
function, using the HABAM, may provide a useful surrogate marker 
for delirium, although further research is required. Additionally, our 
findings, which extend previous cross-sectional studies by using re-
peated measures of the HABAM, reveal that the trajectory of phys-
ical function in those with delirium tended to improve over 14 days, 
especially among those with nonsevere delirium which improved to 
a level similar to that seen in those who never had delirium. This 
improvement is likely to reflect delirium resolution, supported by 
our time-varying analysis, showing that physical function is worse 
on days when delirium is present compared to absent. This also sup-
ports previous work demonstrating that mobility impairments correl-
ated with delirium status (6). Put together, these findings support the 
Figure 2. Examples of the day-by-day variation in total HABAM scores 
in individual participants. This figure shows examples of 4 patients who 
experienced delirium during their admission. The markers show the HABAM 
scores on the days it was assessed, with crosses and circles, indicating days 
when delirium was present and absent, respectively. The modeled lines 
are produced from a linear mixed model with delirium status (present or 
absent) as a time-varying covariate. Horizontal lines show the previously 
recommended cut points: ≤1.25 mild, 1.26–1.74 moderate, and ≥1.75 severe 
functional impairment.
Figure 1. HABAM profiles during the first 14 d of admission in those with 
and without delirium. Predictions (with 95% confidence intervals) from 
linear mixed-effects model with fixed effects for assessment day, delirium 
diagnosis, and the interaction between the 2.  Horizontal lines show the 
previously recommended cut points: ≤1.25 mild, 1.26–1.74 moderate, and 
≥1.75 severe functional impairment.
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assertion that motor disturbances are a core feature of delirium and 
may have utility in differentiating those with and without delirium 
and in defining delirium resolution (5). We have also demonstrated 
that the HABAM, which has previously been shown to predict 
30-day mortality, discharge destination, recovery time, and prevalent 
delirium (10,17), may be a useful tool for this purpose. Having been 
specifically designed to be used by clinicians at the bedside, it over-
comes the floor effects associated with other measures. Further work 
is required to validate the HABAM specifically as a surrogate marker 
of delirium detection and its use to monitor for delirium resolution.
We understand very little about the complex relationships be-
tween physical and cognitive function, and the pathophysiology 
underlying these. We know that both predict poor outcomes, 
including mortality and institutionalization (8), and that each is a 
risk factor for the other (19), but further work is required to ex-
plore the fluctuations in physical function that occur at the time of 
delirium and whether monitoring physical function may provide an 
alternative strategy to improve delirium detection (20).
Trajectories of physical function during hospital admission, re-
corded using the HABAM, differ in older people with and without 
delirium. Our findings support the need for further research into 
whether monitoring physical function, using a tool such as the 
HABAM, may have clinical utility as a surrogate marker for delirium 
and delirium recovery during hospital admission. They also empha-
size the importance of screening for delirium in those with mobility 
below their baseline on admission or a deterioration in their physical 
function during admission.
Supplementary Material
Supplementary data are available at The Journals of Gerontology, 
Series A: Biological Sciences and Medical Sciences online.
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